New triple therapy aims to shrink tough colorectal tumors before surgery
Disease control
Recruiting now
This study tests whether adding a PD-1 immunotherapy drug to standard chemotherapy and bevacizumab can improve outcomes for people with a specific type of advanced colorectal cancer (pMMR/MSS) before surgery. About 166 participants will be randomly assigned to receive either the …
Phase: PHASE3 • Sponsor: Jun Huang • Aim: Disease control
Last updated May 14, 2026 12:03 UTC